Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- VERDICTIndependent statistical analysis of Veterans Response to Dosage in Chiropractic Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04087291).
- VERITASIndependent statistical analysis of A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal…
- VERITASIndependent statistical analysis of Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary: primary endpoint…
- VERITASIndependent statistical analysis of Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- VERiTASIndependent statistical analysis of Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vertebral Body Tethering Outcomes for Pediatric Idiopathic Scoliosis: Complete Statistical AnalysisIndependent statistical analysis of Vertebral Body Tethering Outcomes for Pediatric Idiopathic Scoliosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03194568).
- VERVEIndependent statistical analysis of Virtual-reality and Emotion Regulation in Violence-Exposed Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05022550).
- Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study): Complete Statistical AnalysisIndependent statistical analysis of Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vessel Sparing Prostate Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Vessel Sparing Prostate Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02958787).
- Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01021137).
- Vestibular Intervention Via Portable Electrical Stimulator (VIPES): Complete Statistical AnalysisIndependent statistical analysis of Vestibular Intervention Via Portable Electrical Stimulator (VIPES): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04968197).
- Vestibular Rehabilitation and Otolith Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Vestibular Rehabilitation and Otolith Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02652442).
- Vestibular Stimulation in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Vestibular Stimulation in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02703844).
- Vet-COACHIndependent statistical analysis of Veteran Peer Coaches Optimizing and Advancing Cardiac Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02697422).
- Vfend Special Investigation For Prophylaxis: Complete Statistical AnalysisIndependent statistical analysis of Vfend Special Investigation For Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02674685).
- VFFRCTAIndependent statistical analysis of The Value of CT Fractional Flow Reserve: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03026283).
- VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2: Complete Statistical AnalysisIndependent statistical analysis of VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative…
- VHB-RCTIndependent statistical analysis of Virtual Hope Box - Effectiveness of a Smartphone App for Coping With Suicidal Ideation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VHL3Independent statistical analysis of Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VIAIndependent statistical analysis of Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04633551).
- Viagra in the Treatment of Primary Dysmenorrhea: Complete Statistical AnalysisIndependent statistical analysis of Viagra in the Treatment of Primary Dysmenorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00123162).
- ViBone in Cervical and Lumbar Spine Fusion: Complete Statistical AnalysisIndependent statistical analysis of ViBone in Cervical and Lumbar Spine Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03425682).
- VIBRANTIndependent statistical analysis of Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO): primary endpoint results, effect estimate with confidence…
- Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01394250).
- VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VICARESIndependent statistical analysis of A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements: Complete Statistical AnalysisIndependent statistical analysis of VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VICTASIndependent statistical analysis of Vitamin C, Thiamine, and Steroids in Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03509350).
- VICTORIndependent statistical analysis of Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VICTOR-E1Independent statistical analysis of Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VICTORY-AFIndependent statistical analysis of Evaluation of the Phased Radio Frequency Ablation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693120).
- VICTOSIndependent statistical analysis of Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VIDACTIVA1Independent statistical analysis of Community Intervention to Improve Depressive Symptoms Among Older Adults (VIDACTIVA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06065020).
- Vidaza to Restore Hormone Thx Prostate: Complete Statistical AnalysisIndependent statistical analysis of Vidaza to Restore Hormone Thx Prostate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00384839).
- VIDEOIndependent statistical analysis of Virtual Visits for Postoperative Care Following Urogynecologic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05641077).
- VIDEO-EDIndependent statistical analysis of Video Images About Decisions for Ethical Outcomes in the Emergency Department (VIDEO-ED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Video-visit Behavior Therapy for Anxiety and Depression in Youth: Complete Statistical AnalysisIndependent statistical analysis of Video-visit Behavior Therapy for Anxiety and Depression in Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05417412).
- Viewing Movie Violence & Interest in Guns: Complete Statistical AnalysisIndependent statistical analysis of Viewing Movie Violence & Interest in Guns: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03220412).
- Vigabatrin for Treatment of Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Vigabatrin for Treatment of Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00611130).
- VIH-2Independent statistical analysis of Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VIISTAIndependent statistical analysis of Veterans Inpatient Insulin Study and Transition to Outpatient Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00821795).
- VIKING-3Independent statistical analysis of A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vilazodone for Corticosteroid-Induced Memory Impairment: Complete Statistical AnalysisIndependent statistical analysis of Vilazodone for Corticosteroid-Induced Memory Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01828515).
- Vilazodone Treatment for Marijuana Dependence: Complete Statistical AnalysisIndependent statistical analysis of Vilazodone Treatment for Marijuana Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01574183).
- VillageWhereIndependent statistical analysis of Using Mobile Technology to Enhance Multisystemic Therapy (MST) Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02320903).
- Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing’s Sarcoma Family of Tumors: Complete Statistical AnalysisIndependent statistical analysis of Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vinegar Co-ingestion in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Vinegar Co-ingestion in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01279317).
- VINOIndependent statistical analysis of Vitamins in Nitrous Oxide Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00655980).
- VINOIndependent statistical analysis of Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03050710).